Vyne Therapeutics Inc (NASDAQ:VYNE)
| 5.92 Delayed Data As of Jun 05 |  -0.14 / -2.31%Today’s Change | 1.99 Today|||52-Week Range 9.90 | +119.26% Year-to-Date |
Latest VYNE News | Press Releases
No recent news for Vyne Therapeutics Inc.
Today’s Trading
| Previous close | 6.06 |
| Today’s open | 5.96 |
| Day’s range | 5.87 - 6.06 |
| Volume | 369 |
| Average volume (3 months) | 509,439 |
| Market cap | $19.6M |
Data as of 3:59pm ET, 06/05/2023
Growth & Valuation
| Earnings growth (last year) | +55.78% |
| Earnings growth (this year) | +5.48% |
| Earnings growth (next 5 years) | -53.49% |
| Revenue growth (last year) | -96.77% |
| P/E ratio | NM |
| Price/Sales | 18.03 |
| Price/Book | 0.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FWPAYForward Pharma A/S | 0.00 | 0.00% |
| ALIMAlimera Sciences Inc | +0.16 | +5.97% |
| AGEAgeX Therapeutics In... | +0.01 | +2.75% |
| ---- |
Data as of 3:58pm ET, 06/05/2023
Financials
| Next reporting date | August 11, 2023 |
| EPS forecast (this quarter) | -$2.58 |
| Annual revenue (last year) | $477.0K |
| Annual profit (last year) | -$36.1M |
| Net profit margin | -7,116.35% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
